Articles published by Cosette Pharmaceuticals, Inc.

Cosette Appoints Andrew Adams as Vice President, Supply Chain & Sourcing

September 10, 2026

From Cosette Pharmaceuticals, Inc.

Via Business Wire

Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands)

May 19, 2026

From Cosette Pharmaceuticals, Inc.

Via Business Wire

Tickers HLNE

Cosette Pharmaceuticals Appoints Erika Tooman as Senior Vice President, General Counsel, Strengthening Leadership Team to Drive Accelerated Growth and Strategic Expansion

April 29, 2026

From Cosette Pharmaceuticals, Inc.

Via Business Wire

Cosette Pharmaceuticals Expands Branded Portfolio through Acquisition of SYMPAZAN® and Additional Products from Assertio

April 08, 2026

From Cosette Pharmaceuticals, Inc.

Via Business Wire

Cosette Pharmaceuticals Announces the Approval and Launch of First Generic Version of CIPRO® HC (ciprofloxacin 0.2% HCl and hydrocortisone 1% otic suspension), with 180 days Competitive Generic Therapy (CGT) exclusivity

December 16, 2025

From Cosette Pharmaceuticals, Inc.

Via Business Wire

Termination of Proposed Acquisition of Mayne Pharma

December 11, 2025

From Cosette Pharmaceuticals, Inc.

Via Business Wire

Cosette Pharmaceuticals Appoints Jeff Neubig as Vice President, Quality and Regulatory Affairs

June 30, 2025

From Cosette Pharmaceuticals, Inc.

Via Business Wire

Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women’s Health and Dermatology

February 20, 2025

From Cosette Pharmaceuticals, Inc.

Via Business Wire

Tickers ASX:MYX HLNE

Cosette Pharmaceuticals Appoints Vincent Colicchio as Senior Vice President of Operations

February 10, 2025

From Cosette Pharmaceuticals, Inc.

Via Business Wire

Cosette Pharmaceuticals Appoints Brad Leonard as Vice President, Generics Commercial Operation

February 03, 2025

From Cosette Pharmaceuticals, Inc.

Via Business Wire

Cosette Pharmaceuticals Acquires Ambien® and Ambien CR® (Zolpidem Tartrate) Tabs from Sanofi US in the US Market

July 10, 2024

From Cosette Pharmaceuticals, Inc.

Via Business Wire

Cosette Pharmaceuticals Announces the Approval and Launch of First Generic Version of RECTIV® (nitroglycerin) ointment, 0.4%, with 180 days Competitive Generic Therapy (CGT) exclusivity

February 22, 2024

From Cosette Pharmaceuticals, Inc.

Via Business Wire

Cosette Pharmaceuticals Acquires Vyleesi® (Bremelanotide Injection) from Palatin Technologies Inc.

January 03, 2024

From Cosette Pharmaceuticals, Inc.

Via Business Wire

Tickers PTN

Cosette Pharmaceuticals Launches Metronidazole Vaginal Gel 0.75%, AB-rated to MetroGel-Vaginal® 0.75%

July 27, 2023

From Cosette Pharmaceuticals, Inc.

Via Business Wire

Cosette Pharmaceuticals Launches Dapsone 5% Gel, AB-Rated to Aczone® 5%

July 13, 2023

From Cosette Pharmaceuticals, Inc.

Via Business Wire

EY Announces Apurva Saraf, President and CEO of Cosette Pharmaceuticals as an Entrepreneur Of The Year® 2023 New Jersey Award Winner

June 14, 2023

From Cosette Pharmaceuticals, Inc.

Via Business Wire

Cosette Pharmaceuticals Launches Betaine Anhydrous Powder, AB-rated to Cystadane® (betaine anhydrous for oral solution)

March 02, 2023

From Cosette Pharmaceuticals, Inc.

Via Business Wire

Cosette Pharmaceuticals Announces the launch of Griseofulvin Oral Suspension, 125 mg/5 mL.

December 06, 2022

From Cosette Pharmaceuticals, Inc.

Via Business Wire

Cosette Pharmaceuticals Appoints Kevin Hickey, Vice President, Brand Sales and Marketing to Accelerate Transformation

November 17, 2022

From Cosette Pharmaceuticals, Inc.

Via Business Wire

Cosette Pharmaceuticals Announces the Approval and Launch of First Generic Versions of TAZORAC® (tazarotene) gel, 0.05% and 0.1%, with 180 days Competitive Generic Therapy (CGT) exclusivity

September 20, 2022

From Cosette Pharmaceuticals, Inc.

Via Business Wire

Cosette Pharmaceuticals Appoints Rick Casten as CFO Amid Transformational Growth

July 06, 2022

From Cosette Pharmaceuticals, Inc.

Via Business Wire

Cosette Pharmaceuticals Receives U.S. Patent (US 11,291,628) For Welchol® Chewable Bar, A Novel Oral Drug Delivery System to Deliver Colesevelam Hcl

June 07, 2022

From Cosette Pharmaceuticals, Inc.

Via Business Wire

Cosette Pharmaceuticals and Alembic Pharmaceuticals Limited Announce the Approval and Launch of a National Brand Equivalent (NBE) of Abreva® (Docosanol Cream 10%) Including the First Approval in the Pump Format

May 24, 2022

From Cosette Pharmaceuticals, Inc.

Via Business Wire

Cosette Pharmaceuticals Launches First Injectable Product - Prochlorperazine Edisylate Injection in the U.S.

February 22, 2022

From Cosette Pharmaceuticals, Inc.

Via Business Wire

Cosette Pharmaceuticals Acquires Rights to Eight Branded Products from Daiichi Sankyo

January 18, 2022

From Cosette Pharmaceuticals, Inc.

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.